TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth Tilt how tags are computed

Q4 2025 · 75 positions · Total reported value $2.02B · Top-10 concentration 52.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 75 equity positions with a combined reported value of $2.02B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt.

The largest disclosed positions as of Q4 2025 were AUPH ($180.71M), LKFT ($128.22M), PTCT ($113.94M). By sector, the heaviest allocations are Health Care 81.4%, Technology 1.9%. Versus the prior quarter, allocation shifted toward Other (+2.5pp), Health Care (+0.6pp) and away from Consumer Discretionary (-2.4pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 34% of names.

The largest new positions opened in Q4 2025 were RNAM ($64.92M), CAPR ($49.06M), SPY ($20.46M).

Of the 1 positions fully exited versus the prior quarter, the largest were MRUS ($56.49M), RLAY ($42.12M), VERA ($39.23M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • RNAM AVIDITY BIOSCIENCES INC · $64.92M
  • CAPR CAPRICOR THERAPEUTICS INC · $49.06M
  • SPY STATE STR SPDR S&P 500 ETF T · $20.46M
  • BMY BRISTOL-MYERS SQUIBB CO · $10.79M
  • WVE WAVE LIFE SCIENCES INC · $10.20M
  • CORT CORCEPT THERAPEUTICS INC · $5.46M
  • ABEO ABEONA THERAPEUTICS INC · $5.27M

Fully Exited (vs previous quarter)

  • MRUS MERUS N V · prev qtr: $56.49M
  • RLAY RELAY THERAPEUTICS INC · prev qtr: $42.12M
  • VERA VERA THERAPEUTICS INC · prev qtr: $39.23M · history
  • NKE NIKE INC · prev qtr: $36.22M
  • IONS IONIS PHARMACEUTICALS INC · prev qtr: $35.98M
  • CTMX CYTOMX THERAPEUTICS INC. · prev qtr: $35.30M
  • AVDL AVADEL PHARMACEUTICALS · prev qtr: $32.03M
  • LEGN LEGEND BIOTECH CORP · prev qtr: $27.07M · history

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.4%
Technology 1.9%
Other 16.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 11.33M $180.71M 8.93%
8.93%
Hold
2 3.92M $128.22M 6.33%
6.33%
Reduce
3 1.50M $113.94M 5.63%
5.63%
Hold
4 1.05M $104.73M 5.17%
5.17%
Reduce
5 1.24M $97.63M 4.82%
4.82%
Hold
6 1.19M $97.32M 4.81%
4.81%
Reduce
7 2.26M $93.22M 4.61%
4.61%
Reduce
8 2.63M $91.24M 4.51%
4.51%
Add
9 16.79M $90.17M 4.45%
4.45%
Hold
10 4.57M $73.86M 3.65%
3.65%
Reduce
11 900.00K $64.92M 3.21%
3.21%
New
12 1.33M $64.58M 3.19%
3.19%
Hold
13 1.89M $61.99M 3.06%
3.06%
Reduce
14 1.79M $55.79M 2.76%
2.76%
Reduce
15 1.70M $49.06M 2.42%
2.42%
New
16 470.00K $44.74M 2.21%
2.21%
Add
17 481.44K $38.00M 1.88%
1.88%
Add
18 80.00K $36.27M 1.79%
1.79%
Hold
19 3.86M $34.56M 1.71%
1.71%
Reduce
20 700.00K $26.75M 1.32%
1.32%
Hold
21 2.81M $25.41M 1.25%
1.25%
Reduce
22 127.79K $23.83M 1.18%
1.18%
Reduce
23 5.62M $23.48M 1.16%
1.16%
Reduce
24 30.00K $20.46M 1.01%
1.01%
New
25 692.82K $20.43M 1.01%
1.01%
Add
26 500.00K $17.59M 0.87%
0.87%
Reduce
27 4.81M $17.19M 0.85%
0.85%
Hold
28 500.00K $15.87M 0.78%
0.78%
Hold
29 450.00K $15.56M 0.77%
0.77%
Add
30 23.33K $15.40M 0.76%
0.76%
Reduce
31 300.00K $14.71M 0.73%
0.73%
Reduce
32 1.85M $14.30M 0.71%
0.71%
Hold
33 865.17K $13.84M 0.68%
0.68%
Reduce
34 275.00K $12.69M 0.63%
0.63%
Reduce
35 264.69K $10.91M 0.54%
0.54%
Hold
36 290.29K $10.86M 0.54%
0.54%
Add
37 200.00K $10.79M 0.53%
0.53%
New
38 60.00K $10.44M 0.52%
0.52%
Reduce
39 872.40K $10.35M 0.51%
0.51%
Add
40 600.00K $10.20M 0.50%
0.50%
New
41 1.40M $9.80M 0.48%
0.48%
Hold
42 556.36K $8.56M 0.42%
0.42%
Reduce
43 1.25M $8.28M 0.41%
0.41%
Reduce
44 1.07M $8.26M 0.41%
0.41%
Add
45 350.00K $8.20M 0.41%
0.41%
Reduce
46 6.25M $8.12M 0.40%
0.40%
Add
47 300.00K $8.01M 0.40%
0.40%
Reduce
48 2.13M $7.69M 0.38%
0.38%
Hold
49 349.22K $7.52M 0.37%
0.37%
Reduce
50 6.14M $7.49M 0.37%
0.37%
Add

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, TANG CAPITAL MANAGEMENT LLC reported 75 equity positions worth $2.02B in aggregate; its largest disclosed positions were AUPH ($180.71M), LKFT ($128.22M), PTCT ($113.94M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $2.02B of long equity holdings across 75 positions as of 2025-Q4. Top-10 holdings account for 52.9% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →